Human blood plasma advanced oxidation protein products (AOPP) correlates with fibrinogen levels

Free Radical Research

Volumn 40, Issue 9, 2006, Pages 952-958

  Selmeci, László ^a   Székely, Mária ^a   Soós, Pál ^a   Seres, Leila ^b   Klinga, Nóra ^c   Geiger, Attila ^c   Acsády, György ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b National Institute of Cardiology Budapest   (Hungary)

^c Diachem Ltd   (Hungary)

Author keywords

Advanced oxidation protein products (AOPP); Cardiovascular risk; Fibrinogen; Oxidant stress

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; BIOLOGICAL MARKER; CITRIC ACID; EDETIC ACID; FIBRINOGEN; UNCLASSIFIED DRUG;

ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; GEL PERMEATION CHROMATOGRAPHY; HALF LIFE TIME; HEAT TREATMENT; HUMAN; HUMAN TISSUE; INFLAMMATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PERIPHERAL VASCULAR DISEASE; PROTEIN ANALYSIS; PROTEIN PROCESSING; TEMPERATURE; THROMBOCYTE AGGREGATION; TIME; UREMIA;

BIOLOGICAL MARKERS; BLOOD PROTEINS; FIBRINOGEN; HUMANS; OXIDATION-REDUCTION; OXIDATIVE STRESS; TEMPERATURE; TIME FACTORS;

EID: 33749264088     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.1080/10715760600818789     Document Type: Article

References (34)

1. Witko-Sarsat, V and Friedlander, M and Capeillère-Blandin, C and Nguyen-Khoa, T and Nguyen, AT and Zingraff, J and Jungers, P and Descamps-Latscha, B. (1996) Advanced oxidation protein products as a novel marker of oxidative stress in uremia Kidney Int, 49, pp. 1304-1313.
2. Witko, V and Nguyen, AT and Descamps-Latscha, B. (1992) Microtiter plate assay for phagocyte-derived taurine-chloramines J Clin Lab Anal, 6, pp. 47-53.
3. Capeillère-Blandin, C and Gausson, V and Descamps-Latscha, B and Witko-Sarsat, V. (2004) Biochemical and spectrophotometric significance of advanced oxidized protein products Biochim Biophys Acta, 1689, pp. 91-102.
4. Kaneda, H and Taguchi, J and Ogasawara, K and Aizawa, T and Ohno, M. (2002) Increased level of advanced oxidation protein products in patients with coronary artery disease Atherosclerosis, 162, pp. 221-225.
5. Buonocore, G and Perrone, S and Longini, M and Terzuoli, L and Bracci, R. (2000) Total hydroperoxide and advanced oxidation protein products in preterm hypoxic babies Pediatr Res, 47, pp. 221-224.
6. Buonocore, G and Perrone, S and Longini, M and Vezzosi, P and Marzocchi, B and Paffetti, P and Bracci, R. (2002) Oxidative stress in preterm neonates at birth and on the seventh day of life Pediatr Res, 52, pp. 46-49.
7. Kalousova, M and Skrha, J and Zima, T. (2002) Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus Physiol Res, 51, pp. 597-604.
8. Martin-Gallan, P and Carrascosa, A and Gussinye, M and Dominguez, C. (2003) Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications Free Radic Biol Med, 34, pp. 1563-1574.
9. Allanore, Y and Borderie, D and Lemarechal, H and Ekindjian, OG and Kahan, A. (2004) Acute and sustained effects of dihydropyridine-type calcium channel antagonists on oxidative stress in systemic sclerosis Am J Med, 116, pp. 595-600.
10. Yazici, C and Köse, K and Calis, M and Kuzugüden, S and Kirnap, M. (2004) Protein oxidation status in patients with ankylosing spondylitis Rheumatology (Oxford), 43, pp. 1235-1239.
11. Selmeci, L and Seres, L and Antal, M and Lukäcs, J and Regöly-Mórei, A and Acsády, G. (2005) Advanced oxidation protein products (AOPP) for monitoring oxidative stress in critically ill patients: A simple, fast and inexpensive automated technique Clin Chem Lab Med, 43, pp. 294-297.
12. Descamps-Latscha, B and Witko-Sarsat, V and Nguyen-Khoa, T and Nguyen, AT and Gausson, V and Mothu, N and Cardoso, C and Noël, LH and Guérin, AP and London, GM and Jungers, P. (2004) Early prediction of IgA nephropathy progression: Proteinuria and AOPP are strong prognostic markers Kidney Int, 66, pp. 1606-1612.
13. Collen, D and Tytgat, GN and Claeys, H and Piessens, R. (1972) Metabolism and distribution of fibrinogen. I. Fibrinogen turnover in physiological conditions in humans Br J Hematol, 22, pp. 681-700.
14. Upchurch, GR, Jr and Ramdev, N and Walsh, MT and Loscalzo, J. (1998) Prothrombotic consequences of the oxidation of fibrinogen and their inhibition by aspirin J Thromb Thrombolysis, 5, pp. 9-14.
15. Belisario, MA and Di Domenico, C and Pelagalli, A and Della Morte, R and Staiano, N. (1997) Metal-ion catalyzed oxidation affects fibrinogen activity on platelet aggregation and adhesion Biochimie, 79, pp. 449-455.
16. Shacter, E and Williams, JA and Lim, M and Levine, RL. (1994) Differential susceptibility of plasma proteins to oxidative modification: Examination by western blot immunoassay Free Radic Biol Med, 17, pp. 429-437.
17. Shacter, E and Williams, JA and Levine, RL. (1995) Oxidative modification of fibrinogen inhibits thrombin-catalyzed clot formation Free Radic Biol Med, 18, pp. 815-821.
18. Michelis, R and Gery, R and Sela, S and Shurtz-Swirsky, R and Grinberg, N and Snitkovski, T and Shasha, SM and Kristal, B. (2003) Carbonyl stress induced by intravenous iron during hemodialysis Nephrol Dial Transplant, 18, pp. 924-930.
19. Pignatelli, B and Li, CQ and Boffetta, P and Chen, Q and Ahrens, W and Nyberg, F and Mukeria, A and Bruske-Hohlfeld, I and Fortes, C and Constantinescu, V and Ischiropoulos, H and Ohshima, H. (2001) Nitrated and oxidized plasma proteins in smokers and lung cancer patients Cancer Res, 61, pp. 778-784.
20. Himmelfarb, J and McMonagle, E. (2001) Albumin is the major plasma protein target of oxidant stress in uremia Kidney Int, 60, pp. 358-363.
21. Podrez, EA and Abu-Soud, HM and Hazen, SL. (2000) Myeloperoxidase-generated oxidants and atherosclerosis Free Rad Biol Med, 28, pp. 1717-1725.
22. Korte, W and Riesen, WF. (2001) Comparability of serum and plasma concentrations of haemostasis activation markers Clin Chem Lab Med, 39, pp. 627-630.
23. Park, CT and Wright, SD. (2000) Fibrinogen is a component of a novel lipoprotein particle: Factor H-related protein (FHRP)-associated lipoprotein particle (FALP) Blood, 95, pp. 198-204.
24. Doolittle, RF. (1976) The evolution of vertebrate fibrinogen Fed Proc, 35, pp. 2145-2149.
25. Zhang, SM and Loker, ES. (2004) Representation of an immune responsive gene family encoding fibrinogen-related proteins in the freshwater mollusc Biomphalaria glabrata, an intermediate host for Schistosoma mansoni Gene, 341, pp. 255-266.
26. Kamath, S and Lip, GY. (2003) Fibrinogen: Biochemistry, epidemiology and determinants QJM, 96, pp. 711-729.
27. Koenig, W. (2003) Fibrin(ogen) in cardiovascular disease: An update Thromb Haemost, 89, pp. 601-609.
28. Lind, L. (2003) Circulating markers of inflammation and atherosclerosis Atherosclerosis, 169, pp. 203-214.
29. Hansson, GK. (2005) Mechanisms of disease: Inflammation, atherosclerosis, and coronary artery disease N Engl J Med, 352, pp. 1685-1695.
30. Vadseth, C and Souza, JM and Thomson, L and Seagraves, A and Nagaswami, C and Scheiner, T and Torbet, J and Vilaire, G and Bennett, JS and Murciano, JC and Muzykantov, V and Penn, MS and Hazen, SL and Weisel, JW and Ischiropoulos, H. (2004) Pro-thrombotic state induced by post-translational modification of fibrinogen by reactive nitrogen species J Biol Chem, 279, pp. 8820-8826.
31. Nicholls, SJ and Hazen, SL. (2005) Myeloperoxidase and cardiovascular disease Arterioscler Thromb Vasc Biol, 25, pp. 1102-1111.
32. Descamps-Latscha, B and Witko-Sarsat, V and Nguyen-Khoa, T and Nguyen, AT and Gausson, V and Mothu, N and London, GM and Jungers, P. (2005) Advanced oxidation protein products as risk factors for atherosclerotic cardiovascular events in nondiabetic predialysis patients Am J Kidney Dis, 45, pp. 39-47.
33. Morrow, JD. (2005) Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans Arterioscler Thromb Vasc Biol, 25, pp. 279-286.
34. Davies, MJ. (2005) The oxidative environment and protein damage Biochim Biophys Acta, 1703, pp. 93-109.